Waldron Private Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-288
| Closed | -$205K | – | 399 |
|
|
2024
Q4 | $205K | Sell |
288
-78
| -21% | -$55.6K | 0.01% | 399 |
|
|
2024
Q3 | $385K | Buy |
366
+4
| +1% | +$4.21K | 0.02% | 289 |
|
|
2024
Q2 | $380K | Sell |
362
-7
| -2% | -$7.36K | 0.02% | 275 |
|
|
2024
Q1 | $355K | Buy |
369
+10
| +3% | +$9.63K | 0.02% | 283 |
|
|
2023
Q4 | $315K | Buy |
359
+61
| +20% | +$53.6K | 0.02% | 300 |
|
|
2023
Q3 | $245K | Buy |
298
+4
| +1% | +$3.29K | 0.01% | 320 |
|
|
2023
Q2 | $211K | Sell |
294
-25
| -8% | -$18K | 0.01% | 350 |
|
|
2023
Q1 | $262K | Buy |
+319
| New | +$262K | 0.01% | 345 |
|
|
2017
Q2 | – | Sell |
-652
| Closed | -$240K | – | 190 |
|
|
2017
Q1 | $240K | Sell |
652
-222
| -25% | -$81.7K | 0.06% | 186 |
|
|
2016
Q4 | $320K | Buy |
874
+18
| +2% | +$6.59K | 0.11% | 86 |
|
|
2016
Q3 | $344K | Buy |
856
+18
| +2% | +$7.23K | 0.12% | 80 |
|
|
2016
Q2 | $292K | Sell |
838
-8
| -0.9% | -$2.79K | 0.11% | 105 |
|
|
2016
Q1 | $304K | Buy |
846
+11
| +1% | +$3.95K | 0.11% | 90 |
|
|
2015
Q4 | $453K | Buy |
835
+13
| +2% | +$7.05K | 0.17% | 71 |
|
|
2015
Q3 | $382K | Buy |
822
+57
| +7% | +$26.5K | 0.16% | 60 |
|
|
2015
Q2 | $390K | Buy |
765
+47
| +7% | +$24K | 0.15% | 55 |
|
|
2015
Q1 | $324K | Buy |
718
+213
| +42% | +$96.1K | 0.13% | 62 |
|
|
2014
Q4 | $207K | Buy |
+505
| New | +$207K | 0.09% | 119 |
|